Generic Product News (March 2018)
Generic products featured in the March 2018 edition of Pharmacy Times.
: Aurobindo Pharma
COMPARE TO: Viread (Gilead)
INDICATION: The FDA has approved Aurobindo’s abbreviated new drug application for tenofovir disoproxil fumarate tablets, an AB-rated generic equivalent to Viread. Tenofovir disoproxil fumarate tablets are indicated for the treatment of HIV-1 infection and chronic hepatitis B.
DOSAGE: Dosage form: Tablet: 150, 200, 250, and 300 mg
FOR MORE INFORMATION: aurobindousa.com
: Amneal Pharmaceuticals (AstraZeneca)
COMPARE TO: Entocort EC
INDICATION: Amneal has launched budesonide capsules, 3 mg, an AB-rated equivalent to Entocort EC. Budesonide capsules are indicated for the treatment of mild to moderate active Crohn disease and maintenance of clinical remission of mild to moderate Crohn disease involving the ileum and/or the ascending colon for up to 3 months.
DOSAGE: Capsule: 3 mg
FOR MORE INFORMATION: amneal.com
: Teva Pharmaceuticals
COMPARE TO: Reyataz
INDICATION: Teva has launched a generic version of Reyataz capsules in the United States. Atazanavir sulfate capsules are indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 6 years and older weighing at least 15 kg.
DOSAGE: Capsules: 300 mg
FOR MORE INFORMATION: tevagenerics.com
COMPARE TO: Epiduo Gel, 0.1%/2.5% (Galderma Laboratories)
INDICATION: The FDA has approved Perrigo’s AB-rated generic version of Epiduo (adapalene and benzoyl peroxide) Gel, 0.1%/2.5%. Epiduo Gel is indicated for the topical treatment of acne vulgaris in patients 9 years and older.
FOR MORE INFORMATION: perrigo.com